UNC Health Medication Formulary
Add Formweb to your mobile device
Search results for:
daratumumab
daratumumab
| Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daratumumab | SOLUTION, INTRAVENOUS | 20 mg/mL (5 mL) | ||||||||||||||
| Daratumumab | SOLUTION, INTRAVENOUS | 20 mg/mL (20 mL) | ||||||||||||||
| Daratumumab-Hyaluronidase-fihk | SOLUTION, SUBCUTANEOUS | 1800 mg-30,000 units/15 mL (15 mL) |
Last updated: Jan. 25, 2024
UNC Health
System Formulary Restriction:
Inpatient use of daratumumab injection and daratumumab-hyaluronidase injection is restricted to patients who meet all of the following criteria:
Use for all other indications is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions